secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2022-01-27T23:59:59+00:00
Accession:  0000310764-22-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q4 sales $4.7B (+10.3%), FY21 adj. EPS $9.09 (+22.3%); forecasts FY22 adj. EPS $9.60-10.00
--------------------------------------------------------------------------------

- Q4 net sales $4.7B, +10.3% YoY; organic +9.0% vs 2020, +6.2% vs 2019.
- Q4 reported EPS $1.73 (+16.1%); adjusted EPS $2.71 (-3.6%) year-over-year.
- Full-year net sales $17.1B, +19.2% YoY; reported EPS $5.21 (+24.0%); adjusted EPS $9.09 (+22.3%).
- MedSurg & Neurotech FY organic sales +13.1%; Orthopaedics & Spine FY organic +12.0%.
- 2022 outlook: organic sales growth 6%-8%; adjusted EPS $9.60-$10.00; expects ~1% price headwind.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000008/0000310764-22-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076422000008/syk-20220127.htm
  HTML page:      https://secwatch.observer/filing/0000310764-22-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer